v3.26.1
Condensed Consolidated Statement of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues    
Interest income $ 22,560 $ 15,986
Other revenue 1,673 1,109
Total revenues 24,233 17,095
Expenses    
Interest expense 14,813 10,268
General and administrative expenses 1,183 951
Financing fees 180 161
Management fees 0 0
Performance fees 1,002 560
Total expenses 17,178 11,940
Gains (losses) from operations and financing    
Unrealized gain on loans receivable, at fair value 470 946
Unrealized loss on secured financings, at fair value (156) (251)
Unrealized gain (loss) on derivative instruments, net 855 (982)
(Loss) gain on foreign currency translation (757) 1,195
Total gains from operations and financing, net 412 908
Net income $ 7,467 $ 6,063
Net income per common share, basic $ 0.45 $ 0.54
Net income per common share, diluted $ 0.45 $ 0.54
Weighted-average common shares outstanding, basic 16,664,705 11,304,702
Weighted-average common shares outstanding, diluted [1] 16,665,198 11,305,280
[1] Diluted earnings per share takes into account the effect of dilutive instruments, such as unvested common share awards. As of March 31, 2026 and 2025, 2,832 and 2,932 unvested common shares were outstanding, respectively.